Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.

Source:http://linkedlifedata.com/resource/pubmed/id/15757608

Am. J. Cardiol. 2005 Mar 15 95 6 768-71

Download in:

View as

General Info

PMID
15757608